POSTER SESSION IV
Tuesday, March 27, 2007 — 1:00 PM - 4:30 PM
Exhibit Hall B - 1
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
...then notice the 'Event Added' prompt in the toolbar above as feedback:
GYNECOLOGIC PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
94
Intraoperative Reporting of Ovarian Tumors with Borderline Features
(920)
N Ismiil, S Nofech-Mozes, Z Ghorab, A Covens, R Kupets, MA Khalifa - University of Toronto, Toronto, ON, Canada
Institutional Gynecologic Pathology Review Has an Impact on the Practice of Gynecologic Oncology
(860)
H Asad, R Soslow - Memorial Sloan Kettering Cancer Center, New York, NY
Re-Exploration of the Distinctive Ovarian Lesion Associated with Sclerosing Peritonitis: An Analysis of 25 Cases
(984)
PN Staats, WG McCluggage, PB Clement, RH Young - Massachusetts General Hospital, Boston, MA; Royal Group of Hospitals Trust, Belfast, Ireland; Vancouver General Hospital, Vancouver, BC, Canada
Ovarian Mucinous Borderline Tumor of Intestinal Type: Can We Eliminate the Borderline Category?
(877)
AG Chiesa, E Veras, EG Silva, MT Deavers, L Posligua, A Malpica - The University of Texas M.D. Anderson Cancer Center, Houston, TX; The University of Texas Medical School, Houston, TX
Immunohistochemical Characterization of Ovarian Carcinomas Based on Mucin Production Activity: Analysis of MUC1, MUC2, MUC4, MUC5AC and MUC6 Expression
(914)
K Hirabayashi, H Kajiwara, M Yasuda, RY Osamura - Tokai University School of Medicine, Isehara, Kanagawa, Japan
No Metastatic Endocervical Carcinomas in a Series of p16INK4a-Positive Mucinous Ovarian Adenocarcinomas
(997)
N Wentzensen, A du Bois, S Kommoss, J Pfisterer, D Schmidt, M von Knebel Doeberitz, F Kommoss - Institute of Pathology, Heidelberg, Germany; HSK, Wiesbaden, Germany; Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Institute of Pathology, A2/2, Mannheim, Germany
Ovarian Clear Cell Carcinoma with Prominent Papillary Architecture: A Potential Mimic of Serous Tumor of Low Malignant Potential
(976)
AR Sangoi, RA Soslow, NN Teng, TA Longacre - Stanford Comprehensive Cancer Center, Stanford, CA; Memorial-Sloan Kettering Cancer Center, New York, NY
Analysis of Morphologic Parameters and Expression of ²-Catenin in Endometrioid Carcinoma of the Ovary
(973)
DG Rosen, Z Zhang, J Liu - MD Anderson Cancer Center, Houston, TX
Mutations in the Wnt/ β-Catenin and PI3K/Pten Signaling Pathways Underlie Ovarian Endometrioid Adenocarcinoma Development in Humans and Mice
(998)
R Wu, N Hendrix, R Kuick, DR Schwartz, Y Zhai, ER Fearon, KR Cho - University of Michigan Medical School, Ann Arbor, MI
Granulosa Cell Tumors of the Ovary with a Pseudopapillary Pattern: A Study of 12 Cases of an Unusual Morphologic Variant Emphasizing Their Distinction from Transitional Cell Neoplasms and Other Papillary Ovarian Tumors
(919)
JA Irving, RH Young - Vancouver General Hospital, Vancouver, Canada; Massachusetts General Hospital, Boston, MA
Mast Cells in Sex Cord-Stromal Tumors of the Ovary
(856)
L Andino, A Malpica, ED Euscher, MT Deavers, EG Silva - The University of Texas Medical School at Houston, Houston, TX; The University of Texas MD Anderson Cancer Center, Houston, TX
WT1 Is a Useful Immunohistochemical Marker for the Diagnosis of Ovarian Pure Sertoli Cell Tumor and Facilitates Distinction from Other Non-Sex Cord-Stromal Tumors in the Differential Diagnosis
(1004)
C Zhao, GL Bratthauer, R Barner, R Vang - Magee-Womens Hospital, University of Pittsburgh, Pittsburgh, PA; Johns Hopkins Hospital, Baltimore, MD; Armed Forces Institute of Pathology, Washington, DC
Imbalances of Chromosomes 4, 9 and 12 Are Recurrent in Ovarian Stromal Tumors
(985)
RC Streblow, AJ Dafferner, M Fletcher, W West, RK Stevens, Z Gatalica, D Novak, JA Bridge - University of Nebraska Medical Center, Omaha, NE; Creighton University Medical Center, Omaha, NE
Immunohistochemical Profile of Steroid Cell Tumors of the Ovary. A Useful Tool in Differential Diagnosis with Other Neoplasms with Clear Cell or Eosinophilic Features. Clinico-Pathologic and Immunohistochemical Study of 11 Cases
(924)
MW Jones, G Carter, DJ Dabbs, R Hari - Magee Womens Hospital, University of Pittsburgh, Pittsburgh, PA
Oncofetal Protein Glypican-3 Distinguishes Yolk Sac Tumor from Clear Cell Carcinoma of the Ovary
(893)
GE Esheba, LL Pate, M van de Rijn, TA Longacre - Stanford University, Stanford, CA
Expression of the Urothelial Differentiation Markers GATA3 and Placental S100 (S100P) in Female Genital Tract Transitional Cell Proliferations
(892)
GE Esheba, TA Longacre, JP Higgins - Stanford University, Stanford, CA
Expression of p63 in Brenner Tumors and Transitional Cell Carcinomas of the Gynecologic Tract
(996)
SF Wenson, Z Jiang, B Woda, K Dresser, CS Li - University of Massachusetts Medical School, Worcester, MA
Thyroid Transcription Factor 1 Immunoreactivity in Ovarian Neoplasms
(931)
LA Kubba, J Liu, A Malpica, E Euscher, E Silva, MT Deavers - The University of Texas M.D. Anderson Cancer Center, Houston, TX
Assessment of TTF-1 Immunoreactivity in Ovarian and Uterine Carcinomas and Its Potential Impact on the Differential Diagnosis
(903)
HG Gao, VA LiVolsi, T Pasher, LA Litzky, PJ Zhang - Hospital of the University of Pennsylvania, Philadelphia, PA
A Candidate Precursor to Pelvic Serous Cancer (p53 Signature) and Its Prevalence in Prophylactically Removed Ovaries and Tubes from BRCA+ Women
(898)
AK Folkins, EA Jarboe, Y Lee, TA Ince, R Drapkin, CP Crum - Brigham and Women’s Hospital, Boston, MA
Evidence That Many Primary Peritoneal Serous Carcinomas Originate in the Distal Fallopian Tube
(871)
JW Carlson, D Kindelberger, M Parast, MS Hirsch, A Miron, Y Lee, CP Crum - Brigham and Women’s Hospital, Boston, MA
The Morphologic and Immunophenotypic Spectrum of a Candidate Precursor to Pelvic Serous Carcinoma
(921)
E Jarboe, Y Lee, R Drapkin, FD McKeon, CP Crum - Brigham and Women’s Hospital, Boston, MA; Dana Farber Cancer Research Institute, Boston, MA; Harvard Medical School, Boston, MA
Evidence Supporting a Multi-Step Model of Pelvic Serous Carcinogenesis That Originates in the Tubal Fimbriae
(935)
Y Lee, R Drapkin, A Miron, D Kindelberger, FD McKeon, CP Crum - Brigham and Women’s Hospital, Boston, MA; Harvard Medical School, Boston, MA
“Macropapillary” Serous Carcinoma of the Ovary. A Distinctive Type of Low-Grade Serous Carcinoma.
(1001)
A Yemelyanova, TL Mao, N Nakayama, IM Shih, RJ Kurman - The Johns Hopkins Hospital, Baltimore, MD
The Development of High-Grade Serous Carcinoma from Atypical Proliferative (Borderline) Serous Tumors and Low-Grade Micropapillary Serous Carcinoma — A Morphologic and Molecular Genetic Analysis
(885)
R Dehari, RJ Kurman, S Logani, I Shih - Johns Hopkins Medical Institutions, Baltimore, MD; Emory University School of Medicine, Atlanta, GA
Molecular Genetic and Drug Resistance Data Support Classifying Moderately and Poorly Differentiated Ovarian and Peritoneal Serous Carcinomas into a Single Category
(991)
R Vang, IM Shih, R Salani, E Sugar, RJ Kurman - The Johns Hopkins Hospital, Baltimore, MD; The Johns Hopkins School of Medicine, Baltimore, MD
Evidence That High and Low Grade Ovarian Serous Tumors Reflect Different Cells of Origin
(958)
MM Parast, R Drapkin, F McKeon, D Kindelberger, CP Crum, TA Ince, MS Hirsch - Brigham and Women’s Hospital, Boston, MA; Harvard School of Medicine, Boston, MA
Histologic Patterns of Low Grade Serous Carcinoma of the Ovary — A Tale of Two Concepts
(980)
E Silva, M Deavers, A Malpica - M. D. Anderson Cancer Center, Houston, TX
Estrogen and Progesterone Receptor Expression in Ovarian Carcinomas and Borderline Tumors
(929)
T Kiyokawa, T Hamada, H Hano - Jikei University School of Medicine, Tokyo, Japan
Expression of Maspin in Ovarian Carcinoma, and Its Correlation with Vascular Endothelial Growth Factors A, C and D
(866)
F Bolat, F Kayaselcuk, D Gumurdulu, S Erkanli, H Zeren - Baskent University, Adana, Turkey; Cukurova University, Adana, Turkey
Prognostic Significance of Decreased GATA 4 Expression in Serous Tumors of the Ovary
(999)
JJ Xiong, CE Sheehan, JS Ross - Albany Medical College, Albany, NY
Expression of COX-2, VEGF, Ki-67, and p53 in Advanced Stage, High-Grade Serous Ovarian Carcinoma with Prolonged Survival
(859)
MH Arabi, JP Shah, CS Bryant, RT Morris, V Schimp, M Mughrabi, AR Munkarah, R Ali-Fehmi - Wayne State University, Detroit, MI
Immunohistochemical Analysis of IMP3 in Ovarian Carcinomas: A Clinicopathologic Study
(938)
C Li, ML Anderson, M Lisovsky, A Sienko, P Cagle, A Fraire, D Lu, K Dresser - University of Massachusetts Medical School, Worcester, MA; Baylor College of Medicine, Houston, TX
Microtubule Associated Proteins Involved in Taxans Resistance
(972)
M Romero-Sanchez, R Nadal, BC Ojeda, C Pons, I Landin, I Boguna, V Artigas, A Barnadas, J Prat - Hospital de la Santa Creu i Sant Pau. Autonomous University of Barcelona, Barcelona, Spain
Morphologic and Immunohistochemical Patterns Induced by Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer
(880)
S Chopra, A Mahadavi, K Tewari, I Ramzy - UCI Medical Center, Orange, CA
Loss of LKB1 Protein Expression Is Frequent in High Grade Serous Carcinoma of the Ovary
(988)
A Tone, H Begley, TJ Brown, PA Shaw - University Health Network, Toronto, ON, Canada; Mount Sinai Hospital, Toronto, ON, Canada
Expression of ZBP1, a mRNA Regulating Protein, Is Associated with Progression of Ovarian Carcinoma
(925)
M Köbel, S Hüttelmaier, S Hauptmann - Martin-Luther-University, Halle, Germany
NF-kB p65 Expression Is a Favorable Prognostic Factor in High-Grade Serous Ovarian Carcinoma
(942)
J Liu, DG Rosen - M.D. Anderson Cancer Center, Houston, TX
TP53 Gene Status in Patients with Advanced Ovarian Cancer in Relation to Response to Paclitaxel Plus Platinum-Based Chemotherapy
(911)
D Hardisson, M Mendiola, A Mariño, A Dominguez-Caceres, G Hernandez-Cortes, A Suarez, J Palacios - University Hospital La Paz-UAM, Madrid, Spain; University Hospital Virgen del Rocio, Sevilla, Spain
miRNA Signatures in Primary Versus Recurrent Ovarian Cancers
(955)
SA O’Toole, A Laios, B Sheppard, N Gleeson, T D’Arcy, E McGuinness, M Ring, E Gaffney, C Martin, R Flavin, D Cahill, D O’Connell, J O’Brien, O Sheils, JJ O’Leary - Trinity College Dublin, Dublin, Ireland; University College Dublin, Dublin, Ireland
Recurrence in Ovarian Cancer; a Transcriptomic Approach
(933)
A Laios, SA O’Toole, B Sheppard, N Gleeson, T D’Arcy, E McGuinness, M Ring, R Flavin, C Martin, J O’Brien, D O’Connell, O Sheils, D Cahill, E Gaffney, JJ O’Leary - Trinity College Dublin, Dublin, Ireland; University College Dublin, Dublin, Ireland
Expression of Transcription Factor PAX2 in Ovarian Papillary Serous Carcinoma: An Aid in Differential Diagnosis with Peritoneal Malignant Mesothelioma
(989)
GX Tong, L Chiriboga, D Hamele-Bena, AC Borczuk - Columbia University Medical Center, New York, NY
Potential Use of p53, ER and CA125 Immunohistochemical Panel in Distinction between Endosalpingiosis and Metastatic Carcinomas
(905)
MT Garcia, P Ganjei-Azar - University of Miami, Miami, FL
button next to any title to add to Itinerary Planner...
Add
